mk 0663 has been researched along with Drug Hypersensitivity in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| González-Fernández, T; López-Freire, S; Méndez-Brea, P; Romero-Sánchez, L | 1 |
| Angeletti, F; Kaufmann, R; Meier, F; Meissner, M; Valesky, EM; Zöller, N | 1 |
| Martínez, DM; Ramírez Zuluaga, LF; Rojas-Mejía, DV; Serrano Reyes, CD; Silva Espinosa, DL | 1 |
| Couto, M; Gaspar, Â; López-Salgueiro, R | 1 |
| Blanca, M; Corzo, JL; Gallego, C; Mayorga, C; Muñoz, C; Requena, G; Torres, MJ; Urda, A; Zambonino, MA | 1 |
| Asero, R | 1 |
| Cheng, YK; Gerez, IF; Llanora, GV; Loo, EX; Shek, LP | 1 |
| Gangemi, S; Isola, S; Minciullo, PL; Patanè, M | 1 |
| San Juan de la Parra, S; Segura Arazuri, N; Venturini Díaz, M | 1 |
| Avila, R; Cimbollek, S; Quiralte, J | 1 |
| Antico, A; Bonadonna, P; Dama, A; Pagani, M; Senna, GE; Vescovi, PP | 1 |
| Blanca, M; Blanca-López, N; Campo, P; Canto, G; Doña, I; Fernández, J; Gómez, AI; Jagemann, LR; Laguna, JJ; Rondón, C; Rosado, A; Torres, MJ | 1 |
| Caballero-Fonseca, F; Capriles-Hulett, A; Sánchez-Borges, M | 1 |
| Colanardi, MC; Ferrannini, A; Nettis, E; Tursi, A; Vacca, A | 1 |
| Gaspar, A; Marinho, S; Morais-Almeida, M; Rosa, S; Rosado-Pinto, JE | 1 |
| Al-Herz, AA; Al-Qhouti, BI; Khadadah, ME; Muqim, AT; Nahar, IK; Shehab, DK; Uppal, SS | 1 |
| Calcagnile, F; Calogiuri, G; Ferrannini, A; Muratore, L; Muratore, M; Quarta, E; Ventura, M | 1 |
| Lammintausta, K; Mäkelä, L | 1 |
6 trial(s) available for mk 0663 and Drug Hypersensitivity
| Article | Year |
|---|---|
Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Single-Blind Method; Sulfones | 2010 |
Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Humans; Hypersensitivity, Immediate; Ibuprofen; Pyridines; Single-Blind Method; Sulfones; Urticaria; Young Adult | 2011 |
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Sulfonamides; Sulfones; Urticaria | 2005 |
Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Demography; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Patients; Pyridines; Single-Blind Method; Sulfones | 2005 |
The use of etoricoxib in patients with bronchial asthma associated with aspirin sensitivity.
Topics: Aspirin; Asthma; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Etoricoxib; Humans; Pyridines; Sulfones | 2006 |
Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
Topics: Adult; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Pyridines; Sulfones; Urticaria | 2007 |
12 other study(ies) available for mk 0663 and Drug Hypersensitivity
| Article | Year |
|---|---|
[Selective cyclooxygenase-2 inhibitor hypersensitivity].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Humans; Hypersensitivity; Male; Sulfonamides; Sulfones | 2023 |
Hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) - a retrospective study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Hypersensitivity; Etoricoxib; Humans; Pharmaceutical Preparations; Retrospective Studies | 2020 |
Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bronchial Provocation Tests; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Drug Substitution; Drug Therapy, Combination; Etoricoxib; Humans; Meloxicam | 2021 |
Anaphylaxis to Etoricoxib.
Topics: Anaphylaxis; Basophil Degranulation Test; Basophils; Drug Hypersensitivity; Etoricoxib; Female; Humans; Middle Aged | 2018 |
Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Child; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Drug Substitution; Etoricoxib; Female; Humans; Male; Meloxicam; Pyridines; Retrospective Studies; Sulfones; Thiazines; Thiazoles; Urticaria | 2014 |
Multiple nonsteroidal anti-inflammatory drug-induced cutaneous disease: what differentiates patients with and without underlying chronic spontaneous urticaria?
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diagnosis, Differential; Drug Hypersensitivity; Etoricoxib; Female; Follow-Up Studies; Humans; Immunization; Male; Middle Aged; Pyridines; Sulfones; Tramadol; Urticaria; Young Adult | 2014 |
Etoricoxib: a safe alternative for NSAID intolerance in Asian patients.
Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Sulfones; Young Adult | 2013 |
Mucosal exfoliation as a selective reaction to etoricoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Exfoliation Syndrome; Female; Humans; Mucous Membrane; Pyridines; Sulfones | 2016 |
Selective immediate hypersensitivity to etoricoxib.
Topics: Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Etoricoxib; Humans; Male; Middle Aged; Pyridines; Sulfones; Urticaria | 2008 |
COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Pyrazoles; Pyridines; Sulfonamides; Sulfones | 2009 |
Multiple drug intolerance including etoricoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Hypersensitivity; Etoricoxib; Female; Humans; Hypersensitivity, Immediate; Pyridines; Risk Assessment; Severity of Illness Index; Skin Tests; Sulfones | 2006 |
Etoricoxib-induced acute generalized exanthematous pustulosis.
Topics: Acute Disease; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Exanthema; Humans; Male; Middle Aged; Patch Tests; Pyridines; Skin; Skin Diseases, Vesiculobullous; Sulfones | 2008 |